Lotfy Hala M, Sabry Samar M, Ghobrial Emad E, Abed Samer A
Hemodialysis Unit of Center of Pediatric Nephrology and Transplantation, New Children's Hospital, Faculty of Medicine, Cairo University, Cairo, Egypt.
Saudi J Kidney Dis Transpl. 2015 Mar;26(2):263-70. doi: 10.4103/1319-2442.152416.
Growth failure is one of the most common and profound clinical manifestation of chronic kidney disease (CKD) in infants, children and adolescents. The aim of this study was to assess the nutritional status of Egyptian children with end-stage renal disease (ESRD) on regular hemodialysis (HD). The study included 50 Egyptian children with ESRD on regular HD, following-up at the Pediatric Nephrology unit, Cairo University. History, including dietary history, was taken for all patients and clinical examination was performed on all of them. Body weight, standing height, height or length SD score, the skin fold thickness, mid-arm circumference, mid-arm muscle circumference and mid-arm muscle circumference area were also assessed. The height of the patients was the most affected anthropometric parameter, as 78% of the patients were shorter (height SDS below -3). Body weight is less affected than height, as body weight SDS of 34% of patients was less than -3 SDS. In addition, the body mass index of 16% of the patients was <3 rd percentile, while only 4% of the patients were >97 th percentile. Although most ESRD patients received adequate protein and caloric intake, their growth was markedly affected, especially with longer period on HD. We suggest that assessment of growth parameters should be performed at a minimum period of every six months in children with CKD stages 2-3. For children with more advanced CKD (stages 4-5 and 5D), more frequent evaluation may be warranted due to the greater risk of abnormalities.
生长发育迟缓是婴幼儿、儿童及青少年慢性肾脏病(CKD)最常见且严重的临床表现之一。本研究旨在评估接受定期血液透析(HD)的埃及终末期肾病(ESRD)患儿的营养状况。该研究纳入了50名在开罗大学儿科肾脏病科接受定期HD治疗的埃及ESRD患儿。对所有患者进行了包括饮食史在内的病史采集,并对他们进行了临床检查。还评估了体重、站立身高、身高或身长标准差评分、皮褶厚度、上臂围、上臂肌肉围及上臂肌肉围面积。患者的身高是受影响最大的人体测量参数,78%的患者身高较短(身高标准差评分低于-3)。体重受影响程度低于身高,34%患者的体重标准差评分低于-3标准差。此外,16%患者的体重指数低于第3百分位数,而只有4%的患者高于第97百分位数。尽管大多数ESRD患者摄入了足够的蛋白质和热量,但其生长仍受到显著影响,尤其是HD治疗时间较长的患者。我们建议,对于2-3期CKD患儿,应至少每六个月进行一次生长参数评估。对于更晚期CKD(4-5期和5D期)患儿,由于异常风险更高,可能需要更频繁的评估。